Hi everyone,
I know that the answer to this question may not be as simple
as people would like, but can anyone summarize where in the process the FDA is
in mandating SDTM? There was something about a "proposed rule" but
I'm not sure what that means. Is it mandated for electronic submissions only?
Is a time coming when it will be mandated for all submissions? Same question
goes for ADaM.
Any insight here is appreciated. Thanks.
I’ve posted the same question on the CDISC public
discussion forum.
Michael Molter
Principal
Statistical Programmer - Biostatistics
INC Research
4700 Falls
of
919-926-5710
(work)
919-414-7736
(mobile)
** INC Research is a registered trademark of INC Research, Inc. Notice: This transmission is intended only for the use of the individual or entity to which it is addressed and may contain information that is privileged, confidential and exempt from disclosure. If the reader of this message is not the intended recipient, or an employee or agent responsible for delivering the message to the intended recipient, you are hereby notified that any disclosure, dissemination, distribution or copying of the communication is strictly prohibited. If you have received this communication or any associated attachments in error, please notify the sender immediately. Thank you in advance.